drugset / Trial / NCT00237133
Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women
NaSingle-groupOpen-labelTreatment
Summary
Open-label Phase IV trial of Letrozole 2,5mg po/day for 120 days prior to surgery for patients with locally advanced breast in postmenopausal women expressing hormonal receptors ( ER and PR)
Timeline
- Start
- 2003-03
- Primary completion
- 2009-01
- Completion
- 2009-01-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Letrozole | Other / unclassified | 2.5 mg | Oral |